{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    28,
    29
  ],
  "modelUsed": "gemini-3-flash-preview",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "SAR442168 Arm",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive 60 mg oral SAR442168 daily plus a placebo matching the teriflunomide tablet."
      },
      {
        "id": "arm_2",
        "name": "Teriflunomide Arm",
        "type": {
          "code": "Active Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Active Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive 14 mg oral teriflunomide daily plus a placebo matching the SAR442168 tablet."
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_1"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_2"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_3"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_4"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_5"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_6"
        ],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [],
    "studyElements": [
      {
        "id": "elem_1",
        "name": "SAR442168 Arm - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for SAR442168 Arm during Screening"
      },
      {
        "id": "elem_2",
        "name": "SAR442168 Arm - Treatment Period",
        "instanceType": "StudyElement",
        "description": "Treatment period for SAR442168 Arm during Treatment Period"
      },
      {
        "id": "elem_3",
        "name": "SAR442168 Arm - Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for SAR442168 Arm during Follow-up"
      },
      {
        "id": "elem_4",
        "name": "Teriflunomide Arm - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Teriflunomide Arm during Screening"
      },
      {
        "id": "elem_5",
        "name": "Teriflunomide Arm - Treatment Period",
        "instanceType": "StudyElement",
        "description": "Treatment period for Teriflunomide Arm during Treatment Period"
      },
      {
        "id": "elem_6",
        "name": "Teriflunomide Arm - Follow-up",
        "instanceType": "StudyElement",
        "description": "Treatment period for Teriflunomide Arm during Follow-up"
      }
    ],
    "summary": {
      "armCount": 2,
      "cellCount": 6,
      "cohortCount": 0,
      "elementCount": 6
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Double Blind",
        "codeSystem": "USDM",
        "decode": "Double Blind"
      },
      "maskedRoles": [
        "Subject",
        "Investigator",
        "Caregiver",
        "Outcome Assessor",
        "Data Analyst"
      ],
      "randomizationType": {
        "code": "Randomized",
        "codeSystem": "USDM",
        "decode": "Randomized"
      },
      "allocationRatio": {
        "ratio": "1:1"
      },
      "stratificationFactors": [
        "Expanded Disability Status Scale (EDSS) score at screening (<4 versus ≥4)",
        "Geographic region (US versus non-US)"
      ],
      "controlType": {
        "code": "Active Control",
        "codeSystem": "USDM",
        "decode": "Active Control"
      },
      "armIds": [
        "arm_1",
        "arm_2"
      ],
      "therapeuticAreas": [
        "Neurology",
        "Multiple Sclerosis"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Treatment"
      ],
      "blinding": {
        "schema": "Double Blind",
        "maskedRoles": [
          "Subject",
          "Investigator",
          "Caregiver",
          "Outcome Assessor",
          "Data Analyst"
        ]
      },
      "randomization": {
        "type": "Randomized",
        "allocationRatio": "1:1",
        "stratificationFactors": [
          "Expanded Disability Status Scale (EDSS) score at screening (<4 versus ≥4)",
          "Geographic region (US versus non-US)"
        ]
      },
      "controlType": "Active Control",
      "therapeuticAreas": [
        "Neurology",
        "Multiple Sclerosis"
      ]
    },
    "arms": [
      {
        "name": "SAR442168 Arm",
        "type": "Experimental Arm",
        "description": "Participants receive 60 mg oral SAR442168 daily plus a placebo matching the teriflunomide tablet.",
        "isTitration": false,
        "doseEpochs": null
      },
      {
        "name": "Teriflunomide Arm",
        "type": "Active Comparator",
        "description": "Participants receive 14 mg oral teriflunomide daily plus a placebo matching the SAR442168 tablet.",
        "isTitration": false,
        "doseEpochs": null
      }
    ],
    "cohorts": [],
    "epochs": [
      {
        "name": "Screening",
        "description": "Day -28 to Day -1"
      },
      {
        "name": "Treatment Period",
        "description": "Approximately 18 to 36 months, starting from Day 1 (Randomization)"
      },
      {
        "name": "Follow-up",
        "description": "4 weeks after last dose for participants not entering the Long-term Safety (LTS) study"
      }
    ]
  }
}